There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Similar documents
European Committee on Antimicrobial Susceptibility Testing

ESCMID Online Lecture Library. by author

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

EUCAST recommended strains for internal quality control

European Committee on Antimicrobial Susceptibility Testing

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

Quality assurance of antimicrobial susceptibility testing

Version 1.01 (01/10/2016)

What s new in EUCAST methods?

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Chapter 2. Disk diffusion method

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Defining Resistance and Susceptibility: What S, I, and R Mean to You

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

January 2014 Vol. 34 No. 1

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Performance Information. Vet use only

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

Antimicrobial Susceptibility Testing: The Basics

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

56 Clinical and Laboratory Standards Institute. All rights reserved.

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Main objectives of the EURL EQAS s

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Antibacterial susceptibility testing

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

MRSA surveillance 2014: Poultry

APPENDIX III - DOUBLE DISK TEST FOR ESBL

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

January 2014 Vol. 34 No. 1

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

EDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Background and Plan of Analysis

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

This document is protected by international copyright laws.

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

British Society for Antimicrobial Chemotherapy

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

Intrinsic, implied and default resistance

Theoretical Investigation on Antimicrobial Susceptibility Testing Methods

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

SAMPLE VET08. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals.

Understanding the Hospital Antibiogram

BSAC standardized disc susceptibility testing method (version 8)

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

Media Issued by: LABORATORY MANAGER Original Date: April 11, 2001 Approved by: Laboratory Director Revision Date: February 27, 2004

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

British Society for Antimicrobial Chemotherapy

Prevalence and Drug Resistance Patterns of Staphylococcus Aureus in Lactating Dairy Cow s Milk in Wolayta Sodo, Ethiopia

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Version 9.1 March 2010

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

Antimicrobial Susceptibility Testing: Advanced Course

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Should we test Clostridium difficile for antimicrobial resistance? by author

Version 10.1 April 2011

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

STAPHYLOCOCCI: KEY AST CHALLENGES

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

ESCMID Online Lecture Library. by author

Antimicrobial susceptibility

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders

DO NOT WRITE ON or THROW AWAY THIS PAPER!

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Comparison of tablets and paper discs for antibiotic sensitivity testing

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Determination of antibiotic sensitivities by the

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

Mechanism of antibiotic resistance

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

SENSITITRE. Broth Microdilution (MIC) Method:

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck

C.D.S. USERS GROUP. NEWSLETTER No. 3. Report of the CDS Users Group Workshop held at the. ASM Gold Coast Meeting 1991

EUCAST-and CLSI potency NEO-SENSITABS

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

Version 8 January 2009

Transcription:

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility testing. The CLSI or Clinical and Laboratory Standards Institute is a non-profit organisation with a mission to develop clinical and laboratory practices and promote their use worldwide. Their laboratory testing standards are based on input from and consensus among the industry, governments and healthcare professionals. The CLSI has a Veterinary Subcommittee that approves clinical interpretive breakpoints: this means that the breakpoints of sensitivity discs are related to the actual clinical cure for a certain disease. The EUCAST or European Committee on antimicrobial susceptibility testing is jointly organised by institutions linked to the European Union such as EMA (European Medicines Agency). EUCAST has formed a Veterinary Committee on Antimicrobial Susceptibility Testing (VetCAST). This committee is aimed at dealing with antimicrobial susceptibility testing of bacterial pathogens of animal origin and animal bacteria with zoonotic potential. VetCAST plans to define clinical MIC breakpoints for new veterinary antimicrobial agents, review breakpoints for generic drugs and give advice on the bacterial spectrum of veterinary antimicrobial agents. This handbook is based on the CLSI guidelines, unless otherwise specified. Possible testing methods Agar disc diffusion The agar disc diffusion test is the most widely used and versatile method for antimicrobial susceptibility testing (AST) of a majority of bacterial pathogens. The methodology for this test is described further in this manual. When performed according to recommendations, with careful standardisation and the use of quality controls, disc diffusion is a reproducible and accurate method for AST. Broth microdilution The broth microdilution test is not further described in this manual. Disc diffusion zone diameters and MIC breakpoints from broth microdilution are correlated. However, the zone diameters may not correspond precisely to the listed MIC breakpoints due to differences in the methodologies. Therefore, extrapolation of inhibition zones to MIC values is not possible. Disc diffusion Materials needed Media Mueller-Hinton agar (MHA) without supplements for Enterobacteriaceae, staphylococci and enterococci. Mueller-Hinton agar with blood (MH-F) for streptococci. 14

Figure 1. Use Mueller- Hinton agar with blood (MH-F plates; left) for streptococci and Mueller-Hinton agar (MHA, right) without supplements for Enterobacteriaceae, staphylococci and enterococci. For streptococci, the EUCAST recommends MH-F agar (Mueller-Hinton agar with 5 % horse blood and 20 mg/l beta-nad), while the CLSI recommends MH agar with 5 % sheep blood. The breakpoints published by each organisation are set using their own recommended plates. Figure 2. Antimicrobial paper discs for each antimicrobial to be tested. 15

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Paper discs Antimicrobial paper discs for each antimicrobial to be tested, with the correct dose for the bacterial species to be tested. Discs can be dispensed with single dispensers or multi dispensers. Discs have to be stored in accordance with the guidelines to ensure correct results. Sterile inoculating loop (10 µl size) Disposable plastic inoculating loops or wired inoculating loops (with a Bunsen burner for sterilisation) are used for inoculation of the plates with one loop full of milk. In case mixed cultures grow from milk samples, single colonies can be picked with a sterile inoculating loop to subculture pure colonies. Instructions Obtain single identified colonies With milk obtained aseptically from a mastitic quarter, streak to obtain single colonies on blood agar (Fig. 4). One loop (10 µl) of milk is used to inoculate each plate. When necessary, subculture to obtain pure colonies before preparation of the disc diffusion test. Make an identification of the pure isolate(s). Since breakpoints vary for different species, sensitivity testing without correct identification has very little value. Standardisation of the Tip s concentration of the inoculum is important. If you take too many colonies, the bacteria will be able to overgrow the antibiotic. The resulting inhibition zone will be too small and the bacteria incorrectly identified as resistant. Preparation of the inoculum Suspend 3-5 similar colonies from the agar plate using a sterile loop or cotton swab and suspend in 4-5 ml of sterile 0.9% saline. The density of the colony suspension (inoculum) should be equivalent to 0.5 McFarland and is preferably measured with a photometric device. Alternatively, a 0.5 McFarland standard can be used to visually compare the inoculum. The density can be adjusted by adding more organisms if the density is less than 0.5, or adding more saline if the density is more than 0.5 McFarland. Application of the inoculum The inoculum should be used within 15 minutes of preparation. A sterile cotton swab is immersed in the inoculum and excess fluid removed by turning the swab against the inside of the tube to avoid over-inoculation of the plates. The inoculum is spread evenly over the entire surface of the plate by swabbing in three directions. 16

Method and guidelines Sterile swabs Figure 3. Sterile swabs are used to pick colonies for preparation of the inoculum, and for application of the prepared inoculum on the AST plates. Figure 4. Diagram of a plate-streaking technique and an example of the result of this technique for S. aureus from milk. The goal is to dilute the numbers of bacteria growing in each successive area of the plate as it is rotated and streaked so that isolated colonies will appear on the plate. This technique will enable picking single colonies for AST testing. Figure 5. The density of the inoculum should be equivalent to 0.5 McFarland and is preferably measured with a photometric device. Alternatively, a 0.5 McFarland standard can be used to visually compare the inoculums. 17

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Application of discs Apply the discs firmly on the agar within 15 minutes of preparing the inoculum (otherwise the bacteria start to grow before the discs have been applied, altering the sizes of the inhibition zones). The number of discs should be limited so that overlapping of zones is avoided. Use no more than six discs on a standard 90 mm plate, eight discs on a 100 mm plate and 12 on a 150 mm circular plate. Incubation of plates Invert the plates and incubate them within 15 minutes of disc application. Over-stacking of plates in the incubator may influence the distribution of heat. Incubate the plates for 16-20 hours at 35 ± 2 C before reading. Incubate Enterobacteriaceae, staphylococci and enterococci in ambient air and streptococci in 4-6 % CO 2 enriched air. Examination of plates Examine the growth on the plates. A correct inoculum results in confluent, even growth, with circular inhibition zones. If individual colonies can be seen, the inoculum is too light and the test must be repeated. Reading the zones Zone edges should be read at the point of complete inhibition as judged by the naked eye with the plate held at about 30 cm from the eye. Measure the zone diameter with a ruler, calliper or an automated zone reader. Read MHA plates from the back against a dark background illuminated with reflected light (Fig. 7). Read MH-F plates from the front with the lid removed illuminated with reflected light (Fig. 8). The plates have to be tilted in the light in order to correctly distinguish the outer zones of inhibition. If distinct colonies are observed within an inhibition zone, subculture the colonies, check for purity and repeat the test if necessary. When the colony found within the diffusion zone is not a contamination, the test has to be reported as resistant. Tip s Store discs, including those in dispensers, in sealed containers with a desiccant and protect from light. Store backup stocks at -20 C unless indicated otherwise by the supplier. Store working supplies of discs at < 8 C. To prevent condensation, allow discs to warm to room temperature before opening containers. Dispose of discs appropriately once the expiry date has passed. Reflected light means that a spotlight is directed towards the plate and the light from the spotlight is reflected from the plate to your eyes. This can be seen in figures 8 and 9. It is generally advised that a spotlight is used in the lab for proper inspection of plates. 18

Method and guidelines Figure 6. A visual 0.5 McFarland standard. Figure 7. Measure the zone diameter with a ruler, calliper or an automated zone reader. Read MHA plates from the back against a dark background illuminated with reflected light. Figure 8. For correct reading and measuring of MH-F plates, they have to be evaluated without the lid and illuminated with reflected light. The plates have to be tilted in the light for correct visualisation of the inhibition zones. 19

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Special cases Ampicillin (Enterobacteriaceae) Ignore any fine growth that may appear as an inner zone on some batches of MHA. Penicillin (S. aureus) Sharp zone edges are an indication for resistance in staphylococci (β-lactamase production). Disc diffusion is very reliable for the detection of β-lactamase producers, provided that the zone diameter is measured and the zone edge is closely inspected. Examine with transmitted light (plate held up to light). S. aureus with a sharp zone edge (see Fig. 10) and zone diameter > 26 mm = Resistant. Inducible AmpC resistance (Enterobacteriaceae) AmpC is a resistance gene that codes for β-lactamase. AmpC is not always expressed to the same extent in some Enterobacteriaceae. It has to be induced by an antimicrobial first: clavulanic acid and cefotaxime are strong inducers, ampicillin is only a moderate inducer. For this reason, Enterobacteriaceae that are reported as resistant to cefotaxime or to amoxicillin/clavulanic acid must be reported as resistant to all penicillins and cephalosporins. Detection of inducible clindamycin resistance 4 (D-test) (Staphylococci and streptococci) Some resistance genes need to be triggered before they come into action. Such triggering is more easily induced in the animal than on an agar plate. A simple in vitro test would therefore report them as susceptible, while in the animal, the resistant gen would become active and protect the bacteria against the antibiotic. Such inducible resistance exists for clindamycin. It can be triggered by placing a macrolide agent on the same plate. Place an erythromycin disc and a clindamycin disc next to each other (for staphylococci 12-20 mm apart, for streptococci 12-16 mm apart). Inspect plates illuminated with reflected light. In case of inducible clindamycin resistance, the diffusion zone of the clindamycin disc will reveal a typical D- shaped zone with flattening at the side next to the erythromycin disc (Fig. 11). Trimethoprim-sulfamethoxazole (all bacteria) Sometimes fuzzy zones appear. In this case, inner zones are the ones to be measured. Ignore haze or faint growth up to the disc within an otherwise clear zone (Fig. 9). 4. Fiebelkorn KR et al., 2003. Practical disc diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiology Oct.; 41 (10): 4740-4. 20

Method and guidelines Figure 9. For trimethoprim-sulfamethoxazole, read the inner zones when double zones appear. Ignore haze or faint growth up to the disc within an otherwise clear zone. Figure 10. Penicillin-resistant S. aureus with sharp zone on the left, and penicillin-susceptible S. aureus with a fuzzy zone edge on the left. Figure 11. Typical appearance of inducible clindamycin resistance with a D-shaped zone as a result of a reduced zone diameter at the side next to the erythromycin disc. 21

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Criteria for disc diffusion Gram-positive panel Staphylococci and streptococci Table 1 Antimicrobial Disc Bacteria Zone Reference Observations S( ) R (<) ß-lactams Benzylpenicillin 1 unit STAPH 26 26 STREP 18 18 Oxacillin 1 µg STREP 18 18 Cefoxitin 30 µg SAU 22 22 CNS 25 25 Aminoglycosides Neomycin 10 µg SAU 14 14 Preliminary breakpoint MecA screen ECOFF proposed by EUCAST Gentamicin 10 µg SAU 18 18 CNS 22 22 Kanamycin 30 µg All bacteria 18 14 CLSI 2 Amikacin 30 µg SAU 18 16 CNS 22 19 Macrolides Erythromycin 15 µg STAPH and STREP 21 18 Lincosamides Clindamycin 2 µg STAPH 22 19 STREP 17 17 Trimethoprim sulfonamide combinations Trimethoprim/sulfamethoxazole 1,25/ 23,75 STAPH 17 14 (25) µg STREP 18 15 Tetracyclines Tetracycline 30 µg STAPH 22 19 STREP 23 20 Quinolones Ciprofloxacin 5 µg STAPH 20 20 for all fluorquinoles Full cross- resistance and flumequine Enrofloxacin 5 µg STAPH 23 17 CLSI 2 ß-lactam- aminoglycoside combination Cefalexin + kanamycin (Ubrolexin ) 15/ 30 µg STAPH and STREP 20 18 CLSI 2 and literature 3,4 Validated with pharmacokinetic data in the udder. Penicillin + framycetin (Ubrostar ) 10/ 100 µg STAPH 21 18 STREP 21 19 Literature 5 Validated with pharmacokinetic data in the udder. STAPH: all staphylococci. SAU: Staphylococcus aureus. CNS: coagulase negative staphylococci. STREP: streptococci 22

Method and guidelines Gram-negative panel Enterobacteriaceae Table 2 Antimicrobial Disc Bacteria Zone Reference Observations S( ) R (<) ß-lactams Ampicillin 10 µg Entero 14 14 Amoxicillin-clavulanic acid 20/ 10 µg Entero 19 19 Cefalexin 30 µg Entero 14 14 Cefotaxime 5 µg Entero 20 17 ESBL/ AmpC screen. Aminoglycosides Neomycin 10 µg Entero 12 11 ECOFF proposed by EUCAST. Gentamicine 10 µg Entero 17 14 Kanamycin 30 µg All bacteria 18 14 CLSI 2 Amikacin 30 µg Entero 16 13 Trimethoprim sulfonamide combinations Trimethoprim/ sulfamethoxazole Tetracyclines 1,25 / 23,75 (25) µg Entero 16 13 Tetracycline 30 µg Entero 19 15 CLSI 2 Quinolones Ciprofloxacin 5 µg Entero 22 19 Enrofloxacin 5 µg Entero 23 17 CLSI 2 ß-lactam- aminoglycoside combination Cefalexin + kanamycin (Ubrolexin ) 15/ 30 µg E. coli 20 18 CLSI 2 and literature 4,5 Validated with pharmacokinetic data in the udder. Penicillin + framycetin (Ubrostar ) 10/ 100 µg Entero 18 16 Literature 5 pharmacokinetic data Validated with in the udder. Note: criteria may change; see the EUCAST website or most recent CLSI document. References to tables 1 and 2 1. EUCAST, 2015-01-01. Breakpoint tables for interpretation of MICs and zone diameters. V 5.0. 2. CLSI Vet01-S2., July 2013. Performance standards for antimicrobial disc and dilution susceptibility tests for bacteria isolated from animals; second informational supplement). 3. Pillar et al., 2009. Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: recommendations for a disc diffusion test. J. Dairy Sci., 92: 6217 6227. 4. Silley et al., 2012. Susceptibility of coagulase-negative staphylococci to a kanamycin and cefalexin combination. J. Dairy Sci., 95 :3448 3453. 5. Pillar et al., 2014. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: Development of interpretive criteria for testing by broth microdilution and disc diffusion. J. Dairy Sci., 97 :1 14. 23

ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Quality control Each lab, irrespective of the size or the amount of samples processed, needs a quality control plan. Without regular cross-checking, results lose their validity. Use the control strains specified to monitor the performance of the test. These strains may be purchased from several commercial sources. Store control strains under conditions that will maintain the integrity of the strains. Storage on glass beads at -70 ºC in glycerol broth (or commercial equivalent) is a convenient method. Non-fastidious organisms can be stored at -20 ºC. Subculture a bead on the appropriate non-selective medium every week and check for purity. From this pure culture, subcultures can be prepared for one week. For fastidious organisms that will not survive on plates for five to six days, subculture the strain daily for no more than one week. Acceptable ranges for control strains are in the table below. Control strains should be tested daily until performance is shown to be satisfactory (no more than 1 in 20 tests outside control limits). At this stage, testing frequency may be reduced to once a week. If performance standards are not met, the cause must be investigated. In addition to routine QC testing, participation in a national proficiency test for AST is advised for general feedback on quality improvement. 24

Control strains for QC of AST according to the disc diffusion method, including target and range zones for the specific strains. Table 3 QC strains for AST - disc diffusion method 1 S. aureus ATCC 29213 (NCTC 12973, CIP 103429, DSM 2569, CCUG 15915, CECT 794) Antimicrobial agent Disc content Inhibition zone (mm) Target Range Benzylpenicillin 1 unit 15 12-18 Ampicillin 2 µg 18 15-21 Cefoxitin 30 µg 27 24-30 Gentamicin 10 µg 22 19-25 Erythromycin 15 µg 26 23-29 Clindamycin 2 µg 26 23-29 Trimethoprim-sulfamethoxazole 1.25-23.75 µg 29 22-28 Tetracycline 30 µg 27 23-31 Ciprofloxacin 5 µg 24 21-27 Cefalexin-kanamycin (Ubrolexin ) 15-30 µg - 19-25 Penicillin - framycetin (Ubrostar ) 3 10/ 100 µg - 27-33 Str. pneumoniae ATCC 49619 (NCTC 12977, CIP 104340, DSM 11967, CCUG 33638) Antimicrobial agent Disc content Inhibition zone (mm) Target Range Benzylpenicillin 1 unit 19 16-22 Ampicillin 2 µg 28 25-31 Erythromycin 15 µg 29 26-32 Clindamycin 2 µg 25 22-28 Trimethoprim-sulfamethoxazole 1,25-23,75 µg 23 20-26 Tetracycline 30 µg 31 28-34 Ciprofloxacin 5 µg 25 22-28 Cefalexin-kanamycin (Ubrolexin ) 15-30 µg - 13-20 Penicillin - framycetin (Ubrostar ) 3 10/ 100 µg - 27-33 E.coli ATCC 25922 (NCTC 12241, CIP 76.24, DSM 1103, CCUG 17620, CECT 434) 2 Antimicrobial agent Disc content Inhibition zone (mm) Target Range Ampicillin 10 µg 19 15-22 Amoxicillin-clavulanic acid 20-10 µg 21 18-24 Cefalexin 30 µg 18 15-21 Cefotaxime 5 µg 28 25-31 Gentamicin 10 µg 23 19-26 Ciprofloxacin 5 µg 35 30-40 Trimethoprim-sulfamethoxazole 1.25-23.75 µg 26 23-26 Cefalexin-kanamycin (Ubrolexin ) 15-30 µg - 19-25 Penicillin - framycetin (Ubrostar ) 10/ 100 µg - 18-24 1. EUCAST, Routine and extended internal quality control as recommended by EUCAST, V5.0, 2015-01-09. 2. NCTC, CIP, DSM, CCUG and CECT are alternative sources for the ATCC type of reference strains. 3. CLSI quality control for disc diffusion tested on S. aureus ATCC 25923 and S. pneumoniae ATCC 49619. 25